Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Vanda aims for Argentina
Bizjournals.com
Monday, August 1, 2011 - 1:00pm
tags:
Vanda, Argentina, Biotoscana Farma, schizophrenia, Fanapt
The Eyes Have It: Allergan & Off-Label Marketing
Pharmalot
Monday, August 1, 2011 - 12:11pm
tags:
Allergan, off-label
ARIAD shares rise on EU review of potential cancer drug
Bizjournals.com
Monday, August 1, 2011 - 12:09pm
tags:
Ariad Pharmaceuticals, EU, Merck, ridaforolimus
Former Pfizer Research Chief Says Pharmaceutical Mergers Cripple Science
Forbes
Monday, August 1, 2011 - 12:07pm
tags:
Pfizer, R&D, M&A
Geron Q2/11 Results: Net Loss of $21.1 Million
Seeking Alpha
Monday, August 1, 2011 - 10:31am
tags:
earnings, Geron
Acorda Therapeutics narrows 2nd quarter loss as Amprya sales, expenses climb
Yahoo/AP
Monday, August 1, 2011 - 10:29am
tags:
Acorda Therapeutics, earnings
Court Allows Patents On Breast Cancer Genes
Pharmalot
Monday, August 1, 2011 - 10:28am
tags:
genes, breast cancer, patents, Myriad Genetics, BRCA1, BRCA2
Celgene's Earnings Should Double by 2015
Seeking Alpha
Monday, August 1, 2011 - 10:23am
tags:
Celgene, earnings
Active Biotech shares slump after Phase III result
Marketwatch
Monday, August 1, 2011 - 10:22am
tags:
Active Biotech, laquinimod, Teva Pharmaceuticals, MS, multiple sclerosis
Forest Labs' board urges rejection of Icahn slate
Marketwatch
Monday, August 1, 2011 - 10:20am
tags:
shareholders, Carl Icahn, Forest Labs
Merck and Pfizer: Yielding 4% With Better Growth Prospects Than Utility Stocks
Seeking Alpha
Monday, August 1, 2011 - 10:19am
tags:
Merck, Pfizer
Payer Negotiation is Next Up for AstraZeneca
WSJ Online
Monday, August 1, 2011 - 10:19am
tags:
insurance, payer negotiation, AstraZeneca, Brilinta
Morphosys, Merck & Co. Sign Pact for HuCAL in Vaccine Research
Bloomberg
Monday, August 1, 2011 - 10:17am
tags:
vaccines, MorphoSys, Merck, HuCAL
Here's How Teva Pharmaceutical Industries May Be Failing You
Motley Fool
Sunday, July 31, 2011 - 10:42am
tags:
Teva Pharmaceuticals
Torrent Pharmaceuticals Limited : Torrent Pharma’s profits grow by 38% to Rs. 103 crores
4-traders
Sunday, July 31, 2011 - 10:40am
tags:
Torrent Pharmaceuticals
5 Healthcare Companies With August Catalysts
Seeking Alpha
Sunday, July 31, 2011 - 10:20am
tags:
Regeneron, Shire, NuPathe, Seattle Genetics, Gilead Sciences
Revisiting 6 Speculative Biotech Stocks That Hedge Funds Love
Seeking Alpha
Sunday, July 31, 2011 - 10:18am
tags:
Aeterna Zentaris, Cadence Pharmaceuticals, Dendreon, Arena Pharmaceuticals, Sunesis, Aastrom
The Next Big Thing In Biotech: Spectrum
The Street
Sunday, July 31, 2011 - 10:11am
tags:
Spectrum Pharmaceuticals
Amylin, Eli Lilly & Alkermes submit reply to US FDA on Bydureon
Pharmabiz
Saturday, July 30, 2011 - 12:31pm
tags:
Eli Lilly, Amylin, Alkermes, Bydureon, diabetes
Genzyme and Isis submit European MAA for mipomersen
Pharmabiz
Saturday, July 30, 2011 - 12:26pm
tags:
Genzyme, Isis Pharmaceuticals, mipomersen, hypercholesterolemia

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.